The general and comparative efficacy and safety of duloxetine in major depressive disorder: a systematic review and meta-analysis.
about
Duloxetine versus other anti-depressive agents for depressionSecond-generation antidepressants for seasonal affective disorderSecond-generation antidepressants for seasonal affective disorder (SAD)Using NMR approaches to drive the search for new CNS therapeutics.Continuation treatment of major depressive disorder: is there a case for duloxetine?Comparative clinical profile of mirtazapine and duloxetine in practical clinical settings in Japan: a 4-week open-label, parallel-group study of major depressive disorder.Does adding noradrenaline reuptake inhibition to selective serotonin reuptake inhibition improve efficacy in patients with depression? A systematic review of meta-analyses and large randomised pragmatic trials.Efficacy comparison of duloxetine and SSRIs at doses approved in Japan.Vortioxetine: a meta-analysis of 12 short-term, randomized, placebo-controlled clinical trials for the treatment of major depressive disorderThe effect of initial duloxetine dosing strategy on nausea in korean patients with major depressive disorderIntensive monitoring of duloxetine: results of a web-based intensive monitoring studyEfficacy and safety of duloxetine 60 mg once daily in major depressive disorder: a review with expert commentaryAdverse reactions to duloxetine in depression.A Population Pharmacokinetic-Pharmacodynamic Meta-Analysis of Vortioxetine in Patients with Major Depressive Disorder.Effectiveness of Duloxetine Monotherapy Compared to Combination Therapy with Other Antidepressants in Patients with Major Depressive Disorder: A Short-Term, Retrospective Study.Infant health and neurodevelopmental outcomes following prenatal exposure to duloxetine.Duloxetine in the treatment of binge eating disorder with depressive disorders: a placebo-controlled trial.Duloxetine transfer across the placenta during pregnancy and into milk during lactation.
P2860
Q24198808-6663FA83-AC00-4BBE-8F7A-D7244B08CF3AQ24234341-4B3E4422-C24F-4895-B832-C7808B253F4FQ24234405-A6BA881C-3BF2-4409-A8A6-31D2C1596C71Q33613767-CEF561BE-F14F-4E63-99AD-9AE8A88DFE89Q33755767-DDCEF8DE-2779-4DD8-B02B-C33A990DD970Q34350860-55C7A14E-EE54-4448-AC21-840B19F2E7E0Q34355963-F180B172-60BF-411B-BD20-3F01FF3C5C46Q34977592-4D1721EF-16DF-4701-B00B-F3B3D3E0ADFAQ35536869-627147AC-C941-4778-B63C-25E7986A1F4CQ36463507-91DA9ADB-E110-4CBE-A8B5-DDCB9E439147Q36542573-9D1376E2-67D4-4DA0-856E-B1218AE7F54DQ37449200-C3040C70-25E9-4EDC-8573-F5379C928E69Q37872294-CF9E1A17-E5EA-4436-A5A7-AC78D5935D63Q40366493-1AC6469B-274B-4D98-B57E-997C7BEF589EQ42076509-6526DA94-7163-4E2B-96FB-0EAD3D65A48FQ45949600-68C83F05-A3A3-428A-B258-5AFDC1712538Q47582258-81E7AB0F-0545-4E96-80A5-C08F15876D93Q48901602-4ACA4D85-83B6-423A-9E8B-E544A3D18575
P2860
The general and comparative efficacy and safety of duloxetine in major depressive disorder: a systematic review and meta-analysis.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
The general and comparative ef ...... atic review and meta-analysis.
@ast
The general and comparative ef ...... atic review and meta-analysis.
@en
type
label
The general and comparative ef ...... atic review and meta-analysis.
@ast
The general and comparative ef ...... atic review and meta-analysis.
@en
prefLabel
The general and comparative ef ...... atic review and meta-analysis.
@ast
The general and comparative ef ...... atic review and meta-analysis.
@en
P2860
P31
P50
P1433
P1476
The general and comparative ef ...... atic review and meta-analysis.
@en
P2093
Kylie Thaler
P2860
P304
P356
10.2165/11318930-000000000-00000
P577
2009-01-01T00:00:00Z
P6179
1029639529